Genetics of Gut Dysbiosis

Gut dysbiosis — an imbalanced gut microbiome — is associated with Long COVID, ME/CFS, inflammatory bowel disease, and mental health conditions. Genetic variants in gut immune function, barrier integrity, and microbiome composition influence host-microbiome interactions.

This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.

What is Gut Dysbiosis?

The gut microbiome consists of trillions of bacteria, fungi, and viruses that regulate immune development, metabolic function, and the gut-brain axis. COVID-19 causes gut dysbiosis that persists in some Long COVID patients, with depletion of beneficial bacteria (Bifidobacterium, Faecalibacterium) and overgrowth of opportunistic bacteria. Long COVID patients with gut symptoms show altered microbiome profiles correlating with symptom severity. Genetic variants influencing gut epithelial barrier function (CLDN genes, MUC genes), innate immune sensing (NOD2, CARD9), and gut immune regulation (IL10, IL10RA) shape microbiome composition and response to dysbiosis. The gut-brain axis links microbiome changes to neurological and autonomic symptoms.

Biological pathways commonly discussed in relation to Gut Dysbiosis

Research into Gut Microbiome Dysbiosis and Gut-Brain Axis Genetics has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.

Gut Barrier Function

The intestinal epithelial barrier is maintained by tight junction proteins (CLDN1/3/4, OCLN, TJP1) and mucus layer (MUC2, MUC5B). Variants affecting tight junction integrity cause increased intestinal permeability ('leaky gut'), allowing bacterial products (LPS, peptidoglycan) to enter the systemic circulation and trigger inflammation.

Gut Innate Immunity

NOD2 senses bacterial muramyl dipeptide and is the most important inflammatory bowel disease susceptibility gene. CARD9, STAT3, and IL23R variants in Crohn's disease and ulcerative colitis shape mucosal immune responses. FUT2 (secretor status) affects IgA secretion and microbiome composition.

Gut Brain Axis

The gut-brain axis links gut microbiome composition to neurological function via vagal afferents, short-chain fatty acid signalling (GPR41/43), tryptophan/serotonin metabolism (IDO1, TPH1), and immune mediators. Gut dysbiosis is associated with anxiety, depression, and cognitive symptoms — all common in Long COVID.

Microbiome Immune Crosstalk

Gut bacteria shape systemic immune responses through TLR ligands, SCFAs (butyrate, propionate), and polysaccharide A. SCFA-producing bacteria (Faecalibacterium prausnitzii, Roseburia) have anti-inflammatory effects. IL10 and IL10RA variants affecting mucosal tolerance influence microbiome-immune interactions and IBD susceptibility.

Key genes studied in relation to Gut Dysbiosis

The following genes have been studied in relation to Gut Microbiome Dysbiosis and Gut-Brain Axis Genetics. These genes span the biological pathways most commonly discussed in this area of research.

TLR4

TLR4 is the innate immune sensor for lipopolysaccharide (LPS) from gram-negative bacteria, signaling via MyD88 and TRIF adaptors to activate NF-κB and interferon regulatory factors. It also responds to endogenous danger signals including HMGB1.

AHR

AHR is a ligand-activated transcription factor that senses xenobiotics, tryptophan metabolites (indoles), and other small molecules to regulate xenobiotic metabolism, immune cell differentiation, and circadian functions.

FFAR2

FFAR2 (GPR43) is a G protein-coupled receptor activated by short-chain fatty acids (SCFAs) produced by gut microbiota fermentation, particularly acetate and propionate. It mediates gut-immune crosstalk and regulates inflammatory tone.

FFAR3

FFAR3 (GPR41) responds primarily to propionate and butyrate and is expressed in enteroendocrine cells and the sympathetic nervous system, connecting gut microbial metabolism to autonomic regulation.

CAMP

CAMP encodes the precursor of LL-37, a cathelicidin antimicrobial peptide with broad-spectrum antimicrobial, antiviral, and immunomodulatory activities. LL-37 activates innate immune cells, promotes wound healing, and has anti-biofilm properties.

CARD9

CARD9 is a signaling adaptor that links C-type lectin receptors (Dectin-1, Dectin-2, Mincle) and other pattern recognition pathways to NF-κB activation for antifungal and antibacterial immunity. It also regulates gut microbiome composition.

RORC

RORγt (encoded by RORC isoform 2) is the master transcription factor for Th17 cell differentiation, driving IL-17A, IL-17F, and IL-22 expression. RORC is also expressed in ILC3s and thymocytes.

IL22

IL-22 is a cytokine produced by Th17 cells and ILC3s that signals exclusively in epithelial cells to promote barrier repair, antimicrobial peptide production, and tissue regeneration in the gut, lung, and skin.

14 genes total studied in relation to Gut Dysbiosis across the ChronicDNA dataset.

Genetic variants commonly discussed

The following genetic variants (SNPs) are found in genes that have been studied in relation to Gut Dysbiosis. Each variant represents a position in the genome where individuals may carry different alleles.

rs4986790TLR4 rs4986791TLR4 rs1927914TLR4 rs1007213AHR rs2227485IL22 rs4077515CARD9

41 variants total across genes studied in relation to Gut Dysbiosis.

How personal DNA data may provide educational insights

Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as Gut Dysbiosis.

This is not a diagnostic service. Genetic variants do not determine whether you have Gut Dysbiosis, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.

Related conditions and pathways

Gut Dysbiosis shares biological pathways and genetic associations with the following related conditions and areas of research.

Inflammation Immune Dysregulation Long Covid Chronic Fatigue Mast Cell Activation

Frequently asked questions

How does Long COVID affect the gut microbiome?

COVID-19 causes acute gut dysbiosis with depletion of beneficial bacteria and increased diversity reduction. Some Long COVID patients show persistent microbiome alterations months after infection, with lower Bifidobacterium, Faecalibacterium prausnitzii, and Eubacterium hallii — bacteria associated with gut health and anti-inflammatory SCFA production. These microbiome changes correlate with Long COVID symptom severity in some studies.

What is intestinal permeability and how does it relate to chronic illness?

Intestinal permeability (sometimes called 'leaky gut') refers to reduced tight junction integrity in the gut epithelium, allowing bacterial products like LPS and peptidoglycan to translocate into the bloodstream. This triggers systemic inflammation and has been implicated in ME/CFS, Long COVID, inflammatory bowel disease, and metabolic conditions. Genetic variants in claudin and tight junction genes affect baseline permeability.

What is NOD2 and why is it important for gut immunity?

NOD2 is an intracellular innate immune receptor detecting bacterial muramyl dipeptide. NOD2 loss-of-function variants (R702W, G908R, 1007fs) are the strongest genetic risk factors for Crohn's disease, impairing mucosal bacterial clearance. NOD2 variants affect antimicrobial peptide production in Paneth cells and microbiome composition in the small intestine.

Which gut dysbiosis genes are studied?

Key genes include NOD2, CARD9, STAT3, IL10, IL10RA, FUT2, CLDN1/3, MUC2, TJP1, IDO1, TPH1, and HLA-DQ2/DQ8 (coeliac disease). These cover gut innate immunity, barrier integrity, mucosal tolerance, microbiome composition, and gut-brain axis function.

Explore DNA insights

If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to Gut Dysbiosis and connected biological pathways.

Get Your Personalised DNA Report

Informational and educational only · Not a diagnostic tool · GDPR compliant

14 genes · 41 variants analysed in relation to Gut Dysbiosis